Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
1.200
+0.060 (5.26%)
At close: Sep 5, 2025, 4:00 PM
1.230
+0.030 (2.50%)
After-hours: Sep 5, 2025, 4:10 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Precision Oncology Therapies
7.00M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
7.00M